{"id":190803,"date":"2023-05-23T11:00:00","date_gmt":"2023-05-23T15:00:00","guid":{"rendered":"https:\/\/ibkrcampus.com\/?p=190803"},"modified":"2023-05-23T13:28:54","modified_gmt":"2023-05-23T17:28:54","slug":"in-conversation-with-dr-gordon-sanghera","status":"publish","type":"post","link":"https:\/\/www.interactivebrokers.com\/campus\/traders-insight\/securities\/macro\/in-conversation-with-dr-gordon-sanghera\/","title":{"rendered":"In Conversation with Dr Gordon Sanghera"},"content":{"rendered":"\n<p>One of the first things visitors may notice when they arrive at the headquarters of Oxford Nanopore are the murals that adorn the common spaces. On one wall, there is a picture of the group Nirvana. On another, The Ramones. Blondie features on a third. When I asked my host whether the founders were music fans, I was told, sure, but the important point was that each band depicted had not only challenged prior convention but also invented something new and enduring. It is this mindset that underpins the philosophy of Oxford Nanopore. For your author, it was a privilege to recently spend an hour with the company\u2019s co-founder, Gordon Sanghera, a luminary in the world of life sciences and innovation. Our wide-ranging conversation invoked both Darwin and Copernicus among many other topics.&nbsp;<\/p>\n\n\n\n<p>For those unaware,&nbsp;<a href=\"https:\/\/nanoporetech.com\/\">Oxford Nanopore<\/a>&nbsp;was founded in 2005, with the broad ambition of \u201canyone being able to analyse anything anywhere.\u201d The business listed in 2021 and is currently worth over \u00a32bn. While many would consider what Nanopore has already achieved a marked success, the impression formed when talking with Gordon is that the business is still at a very early stage of its journey. For the team at Nanopore, there is \u201cgrowing momentum\u201d behind its approach to how DNA is sequenced (a topic we first discussed in&nbsp;<a href=\"https:\/\/www.heptagon-capital.com\/reinventing-healthcare-and-the-coming-age-of-personalised-medicine\/\">2012<\/a>). Put simply, the business has developed a proprietary system that allows for greater levels of sequencing accuracy to be achieved at faster speeds than might be possible using more conventional systems such as those developed by industry leader, Illumina. Gordon likened the industry\u2019s incumbents to \u201cflat-earthers\u201d, seeing the world only \u201cin black and white.\u201d By contrast, Nanopore is \u201cbringing colour\u201d to DNA sequencing; an approach it believes will eventually become the orthodoxy (in industry parlance, the Nanopore technique utilises \u2018long reads\u2019 on DNA versus the historic preference for \u2018short reads\u2019).&nbsp;<\/p>\n\n\n\n<p>Oxford Nanopore may well have a chance at success simply because it has always taken a different approach. Gordon arrived at his epiphany through work originally done at the time of his PhD, bringing electronics (and data) to the world of biology. He is also acutely conscious of the importance of innovation. At Nanopore, those responsible for research and development are quite explicitly separated from those involved in the manufacturing of the products, allowing the business to focus on what matters most \u2013 namely, innovation. There is also a distinct focus on creating a platform rather than applications for its platform, a key lesson absorbed from how Apple ended up becoming one of the world&#8217;s most successful companies.<\/p>\n\n\n\n<p>What lessons can be learned from a Future Trends perspective? We have consistently advocated the Darwinian principle that the most successful businesses will be those that are most responsive to change (as opposed either to the strongest or the most intelligent, in Darwin\u2019s summation). Oxford Nanopore embodies this approach \u2013 \u201cwe have to keep innovating through disrupting our own business\u201d, per Gordon. With fewer than 1% of all living things on the planet \u2013 not just humans, but animals and plants too \u2013 sequenced, the runway ahead for the business is significant. As&nbsp;<a href=\"https:\/\/www.heptagon-capital.com\/season-5-post-16-happy-birthday-hgp\/\">costs continue to fall<\/a>, the opportunity should only increase.<\/p>\n\n\n\n<p>&#8212;<\/p>\n\n\n\n<p>Originally Posted May 23, 2023 &#8211; <a href=\"https:\/\/www.heptagon-capital.com\/season-5-post-20-in-conversation-with-dr-gordon-sanghera\/\">In conversation with Dr Gordon Sanghera<\/a><\/p>\n\n\n\n<p><strong><em>The above does not constitute investment advice and is the sole opinion of the author at the time of publication. Past performance is no guide to future performance and the value of investments and income from them can fall as well as rise.<\/em><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p> For your author, it was a privilege to recently spend an hour with the company\u2019s co-founder, Gordon Sanghera, a luminary in the world of life sciences and innovation.<\/p>\n","protected":false},"author":597,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[18,6,8,9,26,3],"tags":[12280,15327,11853],"contributors-categories":[13720],"class_list":{"0":"post-190803","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-macro","7":"category-north-america","8":"category-region","9":"category-securities","10":"category-text-articles","11":"category-traders-insight","12":"tag-dna","13":"tag-dna-sequencing","14":"tag-future-trends","15":"contributors-categories-heptagon-capital"},"pp_statuses_selecting_workflow":false,"pp_workflow_action":"current","pp_status_selection":"publish","acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.9 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>In Conversation with Dr Gordon Sanghera | Traders&#039; Insight<\/title>\n<meta name=\"description\" content=\"For your author, it was a privilege to recently spend an hour with the company\u2019s co-founder, Gordon Sanghera, a luminary in the world of life sciences...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interactivebrokers.com\/campus\/wp-json\/wp\/v2\/posts\/190803\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"In Conversation with Dr Gordon Sanghera | IBKR Campus US\" \/>\n<meta property=\"og:description\" content=\"For your author, it was a privilege to recently spend an hour with the company\u2019s co-founder, Gordon Sanghera, a luminary in the world of life sciences and innovation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interactivebrokers.com\/campus\/traders-insight\/securities\/macro\/in-conversation-with-dr-gordon-sanghera\/\" \/>\n<meta property=\"og:site_name\" content=\"IBKR Campus US\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-23T15:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-23T17:28:54+00:00\" \/>\n<meta name=\"author\" content=\"Alexander Gunz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alexander Gunz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\n\t    \"@context\": \"https:\\\/\\\/schema.org\",\n\t    \"@graph\": [\n\t        {\n\t            \"@type\": \"NewsArticle\",\n\t            \"@id\": \"https:\\\/\\\/www.interactivebrokers.com\\\/campus\\\/traders-insight\\\/securities\\\/macro\\\/in-conversation-with-dr-gordon-sanghera\\\/#article\",\n\t            \"isPartOf\": {\n\t                \"@id\": \"https:\\\/\\\/www.interactivebrokers.com\\\/campus\\\/traders-insight\\\/securities\\\/macro\\\/in-conversation-with-dr-gordon-sanghera\\\/\"\n\t            },\n\t            \"author\": {\n\t                \"name\": \"Alexander Gunz\",\n\t                \"@id\": \"https:\\\/\\\/ibkrcampus.com\\\/campus\\\/#\\\/schema\\\/person\\\/72521bc0f55176f001b1080f6e98bcd9\"\n\t            },\n\t            \"headline\": \"In Conversation with Dr Gordon Sanghera\",\n\t            \"datePublished\": \"2023-05-23T15:00:00+00:00\",\n\t            \"dateModified\": \"2023-05-23T17:28:54+00:00\",\n\t            \"mainEntityOfPage\": {\n\t                \"@id\": \"https:\\\/\\\/www.interactivebrokers.com\\\/campus\\\/traders-insight\\\/securities\\\/macro\\\/in-conversation-with-dr-gordon-sanghera\\\/\"\n\t            },\n\t            \"wordCount\": 594,\n\t            \"commentCount\": 0,\n\t            \"publisher\": {\n\t                \"@id\": \"https:\\\/\\\/ibkrcampus.com\\\/campus\\\/#organization\"\n\t            },\n\t            \"keywords\": [\n\t                \"DNA\",\n\t                \"DNA sequencing\",\n\t                \"future trends\"\n\t            ],\n\t            \"articleSection\": [\n\t                \"Macro\",\n\t                \"North America\",\n\t                \"Region\",\n\t                \"Securities\",\n\t                \"Text Articles\",\n\t                \"Traders' Insight\"\n\t            ],\n\t            \"inLanguage\": \"en-US\",\n\t            \"potentialAction\": [\n\t                {\n\t                    \"@type\": \"CommentAction\",\n\t                    \"name\": \"Comment\",\n\t                    \"target\": [\n\t                        \"https:\\\/\\\/www.interactivebrokers.com\\\/campus\\\/traders-insight\\\/securities\\\/macro\\\/in-conversation-with-dr-gordon-sanghera\\\/#respond\"\n\t                    ]\n\t                }\n\t            ]\n\t        },\n\t        {\n\t            \"@type\": \"WebPage\",\n\t            \"@id\": \"https:\\\/\\\/www.interactivebrokers.com\\\/campus\\\/traders-insight\\\/securities\\\/macro\\\/in-conversation-with-dr-gordon-sanghera\\\/\",\n\t            \"url\": \"https:\\\/\\\/www.interactivebrokers.com\\\/campus\\\/traders-insight\\\/securities\\\/macro\\\/in-conversation-with-dr-gordon-sanghera\\\/\",\n\t            \"name\": \"In Conversation with Dr Gordon Sanghera | IBKR Campus US\",\n\t            \"isPartOf\": {\n\t                \"@id\": \"https:\\\/\\\/ibkrcampus.com\\\/campus\\\/#website\"\n\t            },\n\t            \"datePublished\": \"2023-05-23T15:00:00+00:00\",\n\t            \"dateModified\": \"2023-05-23T17:28:54+00:00\",\n\t            \"description\": \"For your author, it was a privilege to recently spend an hour with the company\u2019s co-founder, Gordon Sanghera, a luminary in the world of life sciences and innovation.\",\n\t            \"inLanguage\": \"en-US\",\n\t            \"potentialAction\": [\n\t                {\n\t                    \"@type\": \"ReadAction\",\n\t                    \"target\": [\n\t                        \"https:\\\/\\\/www.interactivebrokers.com\\\/campus\\\/traders-insight\\\/securities\\\/macro\\\/in-conversation-with-dr-gordon-sanghera\\\/\"\n\t                    ]\n\t                }\n\t            ]\n\t        },\n\t        {\n\t            \"@type\": \"WebSite\",\n\t            \"@id\": \"https:\\\/\\\/ibkrcampus.com\\\/campus\\\/#website\",\n\t            \"url\": \"https:\\\/\\\/ibkrcampus.com\\\/campus\\\/\",\n\t            \"name\": \"IBKR Campus US\",\n\t            \"description\": \"Financial Education from Interactive Brokers\",\n\t            \"publisher\": {\n\t                \"@id\": \"https:\\\/\\\/ibkrcampus.com\\\/campus\\\/#organization\"\n\t            },\n\t            \"potentialAction\": [\n\t                {\n\t                    \"@type\": \"SearchAction\",\n\t                    \"target\": {\n\t                        \"@type\": \"EntryPoint\",\n\t                        \"urlTemplate\": \"https:\\\/\\\/ibkrcampus.com\\\/campus\\\/?s={search_term_string}\"\n\t                    },\n\t                    \"query-input\": {\n\t                        \"@type\": \"PropertyValueSpecification\",\n\t                        \"valueRequired\": true,\n\t                        \"valueName\": \"search_term_string\"\n\t                    }\n\t                }\n\t            ],\n\t            \"inLanguage\": \"en-US\"\n\t        },\n\t        {\n\t            \"@type\": \"Organization\",\n\t            \"@id\": \"https:\\\/\\\/ibkrcampus.com\\\/campus\\\/#organization\",\n\t            \"name\": \"Interactive Brokers\",\n\t            \"alternateName\": \"IBKR\",\n\t            \"url\": \"https:\\\/\\\/ibkrcampus.com\\\/campus\\\/\",\n\t            \"logo\": {\n\t                \"@type\": \"ImageObject\",\n\t                \"inLanguage\": \"en-US\",\n\t                \"@id\": \"https:\\\/\\\/ibkrcampus.com\\\/campus\\\/#\\\/schema\\\/logo\\\/image\\\/\",\n\t                \"url\": \"https:\\\/\\\/www.interactivebrokers.com\\\/campus\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2024\\\/05\\\/ibkr-campus-logo.jpg\",\n\t                \"contentUrl\": \"https:\\\/\\\/www.interactivebrokers.com\\\/campus\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2024\\\/05\\\/ibkr-campus-logo.jpg\",\n\t                \"width\": 669,\n\t                \"height\": 669,\n\t                \"caption\": \"Interactive Brokers\"\n\t            },\n\t            \"image\": {\n\t                \"@id\": \"https:\\\/\\\/ibkrcampus.com\\\/campus\\\/#\\\/schema\\\/logo\\\/image\\\/\"\n\t            },\n\t            \"publishingPrinciples\": \"https:\\\/\\\/www.interactivebrokers.com\\\/campus\\\/about-ibkr-campus\\\/\",\n\t            \"ethicsPolicy\": \"https:\\\/\\\/www.interactivebrokers.com\\\/campus\\\/cyber-security-notice\\\/\"\n\t        },\n\t        {\n\t            \"@type\": \"Person\",\n\t            \"@id\": \"https:\\\/\\\/ibkrcampus.com\\\/campus\\\/#\\\/schema\\\/person\\\/72521bc0f55176f001b1080f6e98bcd9\",\n\t            \"name\": \"Alexander Gunz\",\n\t            \"url\": \"https:\\\/\\\/www.interactivebrokers.com\\\/campus\\\/author\\\/alexander-gunz\\\/\"\n\t        }\n\t    ]\n\t}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"In Conversation with Dr Gordon Sanghera | Traders' Insight","description":"For your author, it was a privilege to recently spend an hour with the company\u2019s co-founder, Gordon Sanghera, a luminary in the world of life sciences...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interactivebrokers.com\/campus\/wp-json\/wp\/v2\/posts\/190803\/","og_locale":"en_US","og_type":"article","og_title":"In Conversation with Dr Gordon Sanghera | IBKR Campus US","og_description":"For your author, it was a privilege to recently spend an hour with the company\u2019s co-founder, Gordon Sanghera, a luminary in the world of life sciences and innovation.","og_url":"https:\/\/www.interactivebrokers.com\/campus\/traders-insight\/securities\/macro\/in-conversation-with-dr-gordon-sanghera\/","og_site_name":"IBKR Campus US","article_published_time":"2023-05-23T15:00:00+00:00","article_modified_time":"2023-05-23T17:28:54+00:00","author":"Alexander Gunz","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Alexander Gunz","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.interactivebrokers.com\/campus\/traders-insight\/securities\/macro\/in-conversation-with-dr-gordon-sanghera\/#article","isPartOf":{"@id":"https:\/\/www.interactivebrokers.com\/campus\/traders-insight\/securities\/macro\/in-conversation-with-dr-gordon-sanghera\/"},"author":{"name":"Alexander Gunz","@id":"https:\/\/ibkrcampus.com\/campus\/#\/schema\/person\/72521bc0f55176f001b1080f6e98bcd9"},"headline":"In Conversation with Dr Gordon Sanghera","datePublished":"2023-05-23T15:00:00+00:00","dateModified":"2023-05-23T17:28:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interactivebrokers.com\/campus\/traders-insight\/securities\/macro\/in-conversation-with-dr-gordon-sanghera\/"},"wordCount":594,"commentCount":0,"publisher":{"@id":"https:\/\/ibkrcampus.com\/campus\/#organization"},"keywords":["DNA","DNA sequencing","future trends"],"articleSection":["Macro","North America","Region","Securities","Text Articles","Traders' Insight"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.interactivebrokers.com\/campus\/traders-insight\/securities\/macro\/in-conversation-with-dr-gordon-sanghera\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.interactivebrokers.com\/campus\/traders-insight\/securities\/macro\/in-conversation-with-dr-gordon-sanghera\/","url":"https:\/\/www.interactivebrokers.com\/campus\/traders-insight\/securities\/macro\/in-conversation-with-dr-gordon-sanghera\/","name":"In Conversation with Dr Gordon Sanghera | IBKR Campus US","isPartOf":{"@id":"https:\/\/ibkrcampus.com\/campus\/#website"},"datePublished":"2023-05-23T15:00:00+00:00","dateModified":"2023-05-23T17:28:54+00:00","description":"For your author, it was a privilege to recently spend an hour with the company\u2019s co-founder, Gordon Sanghera, a luminary in the world of life sciences and innovation.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interactivebrokers.com\/campus\/traders-insight\/securities\/macro\/in-conversation-with-dr-gordon-sanghera\/"]}]},{"@type":"WebSite","@id":"https:\/\/ibkrcampus.com\/campus\/#website","url":"https:\/\/ibkrcampus.com\/campus\/","name":"IBKR Campus US","description":"Financial Education from Interactive Brokers","publisher":{"@id":"https:\/\/ibkrcampus.com\/campus\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibkrcampus.com\/campus\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ibkrcampus.com\/campus\/#organization","name":"Interactive Brokers","alternateName":"IBKR","url":"https:\/\/ibkrcampus.com\/campus\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ibkrcampus.com\/campus\/#\/schema\/logo\/image\/","url":"https:\/\/www.interactivebrokers.com\/campus\/wp-content\/uploads\/sites\/2\/2024\/05\/ibkr-campus-logo.jpg","contentUrl":"https:\/\/www.interactivebrokers.com\/campus\/wp-content\/uploads\/sites\/2\/2024\/05\/ibkr-campus-logo.jpg","width":669,"height":669,"caption":"Interactive Brokers"},"image":{"@id":"https:\/\/ibkrcampus.com\/campus\/#\/schema\/logo\/image\/"},"publishingPrinciples":"https:\/\/www.interactivebrokers.com\/campus\/about-ibkr-campus\/","ethicsPolicy":"https:\/\/www.interactivebrokers.com\/campus\/cyber-security-notice\/"},{"@type":"Person","@id":"https:\/\/ibkrcampus.com\/campus\/#\/schema\/person\/72521bc0f55176f001b1080f6e98bcd9","name":"Alexander Gunz","url":"https:\/\/www.interactivebrokers.com\/campus\/author\/alexander-gunz\/"}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/ibkrcampus.com\/campus\/wp-json\/wp\/v2\/posts\/190803","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibkrcampus.com\/campus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibkrcampus.com\/campus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibkrcampus.com\/campus\/wp-json\/wp\/v2\/users\/597"}],"replies":[{"embeddable":true,"href":"https:\/\/ibkrcampus.com\/campus\/wp-json\/wp\/v2\/comments?post=190803"}],"version-history":[{"count":0,"href":"https:\/\/ibkrcampus.com\/campus\/wp-json\/wp\/v2\/posts\/190803\/revisions"}],"wp:attachment":[{"href":"https:\/\/ibkrcampus.com\/campus\/wp-json\/wp\/v2\/media?parent=190803"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibkrcampus.com\/campus\/wp-json\/wp\/v2\/categories?post=190803"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibkrcampus.com\/campus\/wp-json\/wp\/v2\/tags?post=190803"},{"taxonomy":"contributors-categories","embeddable":true,"href":"https:\/\/ibkrcampus.com\/campus\/wp-json\/wp\/v2\/contributors-categories?post=190803"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}